200
Participants
Start Date
December 4, 2024
Primary Completion Date
December 20, 2026
Study Completion Date
December 31, 2027
Doxycycline
Doxycycline is a bacteriostatic tetracycline antibiotic with ability to immunomodulate matrix metalloproteinases, enzymes well known to cause lung damage via breakdown lung extracellular matrix.
Placebo
This will be a chemically inert substance, designed to match oral doxycycline capsules but with no chemically active ingredients.
NOT_YET_RECRUITING
Makerere University Lung Institute, Kampala
RECRUITING
Mulago National Referral Hospital, Kampala
Makerere University Lung Institute
UNKNOWN
Makerere University
OTHER